| # | Title | Journal | Year | Citations |
|---|
|
| 1 | Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer | Journal of Clinical Oncology | 2008 | 1,671 |
| 2 | SOAPnuke: a MapReduce acceleration-supported software for integrated quality control and preprocessing of high-throughput sequencing data | GigaScience | 2018 | 1,447 |
| 3 | WEGO 2.0: a web tool for analyzing and plotting GO annotations, 2018 update | Nucleic Acids Research | 2018 | 498 |
| 4 | Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study | Lancet Oncology, The | 2020 | 437 |
| 5 | Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial | Lancet Oncology, The | 2020 | 404 |
| 6 | Autophagy-dependent ferroptosis drives tumor-associated macrophage polarization via release and uptake of oncogenic KRAS protein | Autophagy | 2020 | 363 |
| 7 | Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432 | Annals of Oncology | 2019 | 354 |
| 8 | Lipid storage and lipophagy regulates ferroptosis | Biochemical and Biophysical Research Communications | 2019 | 318 |
| 9 | Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial | Lancet Respiratory Medicine,the | 2021 | 305 |
| 10 | Ferroptotic damage promotes pancreatic tumorigenesis through a TMEM173/STING-dependent DNA sensor pathway | Nature Communications | 2020 | 251 |
| 11 | Wnt/β-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance | Genes and Diseases | 2016 | 226 |
| 12 | Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR) | Journal of Clinical Oncology | 2022 | 199 |
| 13 | Ferroptosis is a lysosomal cell death process | Biochemical and Biophysical Research Communications | 2018 | 190 |
| 14 | Epigenetics-Based Tumor Cells Pyroptosis for Enhancing the Immunological Effect of Chemotherapeutic Nanocarriers | Nano Letters | 2019 | 182 |
| 15 | Colorectal cancer-derived small extracellular vesicles establish an inflammatory premetastatic niche in liver metastasis | Carcinogenesis | 2018 | 180 |
| 16 | ABO Blood Group and Risk of Coronary Heart Disease in Two Prospective Cohort Studies | Arteriosclerosis, Thrombosis, and Vascular Biology | 2012 | 172 |
| 17 | ESCRT-III–dependent membrane repair blocks ferroptosis | Biochemical and Biophysical Research Communications | 2020 | 162 |
| 18 | AIFM2 blocks ferroptosis independent of ubiquinol metabolism | Biochemical and Biophysical Research Communications | 2020 | 161 |
| 19 | A Ratiometric Fluorescent Bioprobe Based on Carbon Dots and Acridone Derivate for Signal Amplification Detection Exosomal microRNA | Analytical Chemistry | 2018 | 157 |
| 20 | Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer | JAMA - Journal of the American Medical Association | 2022 | 157 |
| 21 | miR-141 Is a Key Regulator of Renal Cell Carcinoma Proliferation and Metastasis by Controlling EphA2 Expression | Clinical Cancer Research | 2014 | 145 |
| 22 | Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study | Lancet, The | 2023 | 134 |
| 23 | Epigenetic modulation of antitumor immunity for improved cancer immunotherapy | Molecular Cancer | 2021 | 133 |
| 24 | Prevalence and associated factors of depression and anxiety among nurses during the outbreak of COVID-19 in China: A cross-sectional study | International Journal of Nursing Studies | 2021 | 129 |
| 25 | Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial | Lancet, The | 2021 | 117 |
| 26 | Circulating Epstein–Barr virus microRNAs miR‐BART7 and miR‐BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment | International Journal of Cancer | 2015 | 108 |
| 27 | Amplified Visualization of Protein-Specific Glycosylation in Zebrafish via Proximity-Induced Hybridization Chain Reaction | Journal of the American Chemical Society | 2018 | 108 |
| 28 | lncRNA H19 mediates BMP9-induced osteogenic differentiation of mesenchymal stem cells (MSCs) through Notch signaling | Oncotarget | 2017 | 106 |
| 29 | Anticancer activity of green synthesised gold nanoparticles from Marsdenia tenacissima inhibits A549 cell proliferation through the apoptotic pathway | Artificial Cells, Nanomedicine and Biotechnology | 2019 | 94 |
| 30 | Surgical treatment and prognosis of gastric cancer in 2 613 patients | World Journal of Gastroenterology | 2004 | 93 |
| 31 | MAGE-TRIM28 complex promotes the Warburg effect and hepatocellular carcinoma progression by targeting FBP1 for degradation | Oncogenesis | 2017 | 93 |
| 32 | Reactive cutaneous capillary endothelial proliferation in advanced hepatocellular carcinoma patients treated with camrelizumab: data derived from a multicenter phase 2 trial | Journal of Hematology and Oncology | 2020 | 89 |
| 33 | DNA Copy Numbers Profiles in Affinity-Purified Ovarian Clear Cell Carcinoma | Clinical Cancer Research | 2010 | 85 |
| 34 | Efficacy and Biomarker Analysis of Camrelizumab in Combination with Apatinib in Patients with Advanced Nonsquamous NSCLC Previously Treated with Chemotherapy | Clinical Cancer Research | 2021 | 85 |
| 35 | Camrelizumab Plus Apatinib in Extensive-Stage SCLC (PASSION): A Multicenter, Two-Stage, Phase 2 Trial | Journal of Thoracic Oncology | 2021 | 84 |
| 36 | LncRNA NEAT1 enhances the radio-resistance of cervical cancer via miR-193b-3p/CCND1 axis | Oncotarget | 2018 | 83 |
| 37 | Noncanonical Wnt signaling plays an important role in modulating canonical Wnt-regulated stemness, proliferation and terminal differentiation of hepatic progenitors | Oncotarget | 2017 | 82 |
| 38 | Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial | Nature Medicine | 2021 | 78 |
| 39 | Targeting the miR-221–222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma | Cancer Research | 2015 | 76 |
| 40 | Apatinib Plus Gefitinib as First-Line Treatment in Advanced EGFR-Mutant NSCLC: The Phase III ACTIVE Study (CTONG1706) | Journal of Thoracic Oncology | 2021 | 76 |
| 41 | Impact of intensity-modulated radiotherapy on nasopharyngeal carcinoma: Validation of the 7th edition AJCC staging system | Oral Oncology | 2015 | 75 |
| 42 | Overexpression of G protein-coupled receptor GPR87 promotes pancreatic cancer aggressiveness and activates NF-κB signaling pathway | Molecular Cancer | 2017 | 75 |
| 43 | ROCK1 as a potential therapeutic target in osteosarcoma | Journal of Orthopaedic Research | 2011 | 74 |
| 44 | Fructose-1,6-bisphosphatase Inhibits ERK Activation and Bypasses Gemcitabine Resistance in Pancreatic Cancer by Blocking IQGAP1–MAPK Interaction | Cancer Research | 2017 | 74 |
| 45 | Distant metastasis risk and patterns of nasopharyngeal carcinoma in the era of IMRT: long-term results and benefits of chemotherapy | Oncotarget | 2015 | 72 |
| 46 | Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study | Lancet Respiratory Medicine,the | 2021 | 72 |
| 47 | MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway | Oncotarget | 2015 | 71 |
| 48 | The Roles of the Let-7 Family of MicroRNAs in the Regulation of Cancer Stemness | Cells | 2021 | 66 |
| 49 | A comparative dosimetric study of left sided breast cancer after breast-conserving surgery treated with VMAT and IMRT | Radiation Oncology | 2015 | 65 |
| 50 | Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma | JAMA - Journal of the American Medical Association | 2022 | 65 |
